BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33737704)

  • 21. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault C; Pagnoux C; Jayne D; Guillevin L; Cordier JF;
    Autoimmun Rev; 2017 Jan; 16(1):1-9. PubMed ID: 27671089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypereosinophilic syndromes.
    Kahn JE; Blétry O; Guillevin L
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):863-82. PubMed ID: 19028368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical approach to the patient with hypereosinophilia.
    Roufosse F; Weller PF
    J Allergy Clin Immunol; 2010 Jul; 126(1):39-44. PubMed ID: 20538328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First report of FIP1L1-PDGFRα-positive eosinophilic granulomatosis with polyangiitis.
    Emmi G; Silvestri E; Marconi R; Carrai V; Fanelli T; Zucchini P; Marasca R; Vannucchi AM; Emmi L; Prisco D; Vaglio A
    Rheumatology (Oxford); 2015 Sep; 54(9):1751-3. PubMed ID: 26106208
    [No Abstract]   [Full Text] [Related]  

  • 25. The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease.
    Yamada Y; Rothenberg ME; Lee AW; Akei HS; Brandt EB; Williams DA; Cancelas JA
    Blood; 2006 May; 107(10):4071-9. PubMed ID: 16418325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypereosinophilic syndrome, Churg-Strauss syndrome and parasitic diseases: possible links between eosinophilia and thrombosis.
    Maino A; Rossio R; Cugno M; Marzano AV; Tedeschi A
    Curr Vasc Pharmacol; 2012 Sep; 10(5):670-5. PubMed ID: 22272911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causes of hypereosinophilia in 100 consecutive patients.
    Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
    Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypereosinophilic syndrome in the differential diagnosis of pulmonary infiltrates with eosinophilia.
    Zimmermann N; Wikenheiser-Brokamp KA
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):179-185. PubMed ID: 29803709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilic leukocytoclastic vasculitis - a spectrum ranging from Wells' syndrome to Churg-Strauss syndrome?
    Ratzinger G; Zankl J; Eisendle K; Zelger B
    Eur J Dermatol; 2014; 24(5):603-10. PubMed ID: 25115356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.
    Pardanani A; Ketterling RP; Brockman SR; Flynn HC; Paternoster SF; Shearer BM; Reeder TL; Li CY; Cross NC; Cools J; Gilliland DG; Dewald GW; Tefferi A
    Blood; 2003 Nov; 102(9):3093-6. PubMed ID: 12842979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypereosinophilic syndrome: endomyocardial biopsy versus echocardiography to diagnose cardiac involvement.
    Butterfield JH; Kane GC; Weiler CR
    Postgrad Med; 2017 Jun; 129(5):517-523. PubMed ID: 28440714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia.
    Cools J; Stover EH; Wlodarska I; Marynen P; Gilliland DG
    Curr Opin Hematol; 2004 Jan; 11(1):51-7. PubMed ID: 14676627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations.
    Leiva O; Baker O; Jenkins A; Brunner AM; Al-Samkari H; Leaf RK; Rosovsky RP; Fathi AT; Weitzman J; Bornikova L; Nardi V; Hobbs GS
    JAMA Netw Open; 2021 Aug; 4(8):e2119812. PubMed ID: 34357393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Portal vein thrombosis associated with idiopathic hypereosinophilic syndrome].
    Kaito S; Harada S; Tsukada M; Kojima A; Iwama K; Yamada K; Kajiwara K; Morikawa K; Shimizu K; Kozai Y; Koudo H
    Rinsho Ketsueki; 2018; 59(1):45-50. PubMed ID: 29415937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New insights into hypereosinophilic syndromes].
    Bletry O; Kahn JE; Ackermann F; Charles P; Legrand F
    Bull Acad Natl Med; 2010 Mar; 194(3):547-59; discussion 559-60. PubMed ID: 21171248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases.
    La Starza R; Specchia G; Cuneo A; Beacci D; Nozzoli C; Luciano L; Aventin A; Sambani C; Testoni N; Foppoli M; Invernizzi R; Marynen P; Martelli MF; Mecucci C
    Haematologica; 2005 May; 90(5):596-601. PubMed ID: 15921374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonality of isolated eosinophils in the hypereosinophilic syndrome.
    Chang HW; Leong KH; Koh DR; Lee SH
    Blood; 1999 Mar; 93(5):1651-7. PubMed ID: 10029594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase: case report.
    Rodzaj M; Gałazka K; Majewski M; Zduńczyk A
    Pol Arch Med Wewn; 2009 Dec; 119(12):838-41. PubMed ID: 20010473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Hypereosinophilic Syndromes.
    Roufosse F
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):561-75. PubMed ID: 26209900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T6741 mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy.
    Ohnishi H; Kandabashi K; Maeda Y; Kawamura M; Watanabe T
    Br J Haematol; 2006 Sep; 134(5):547-9. PubMed ID: 16856885
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.